The Hidden Costs of Healthcare Innovations

 

Technological advancements in the healthcare industry can be shockingly effective. They also can exert a significant impact on a hospital’s budget. On this episode of Full Circle Healthcare, a Mesphere Systems podcast, David Macfarlane, Marketing Communications Manager for Medsphere Systems, sat down with host Sean Heath to discuss the challenges of adopting the latest and greatest technologies.

The initial cost of a new healthcare technology can vary widely, based on the size/scope of the product, Macfarlane said.

“If you’re looking at the entire range of IT products, specific to healthcare, so, we’re talking about an entire healthcare platform. An electronic health record that runs a whole hospital, or a healthcare system, and then you could scale all the way down to a single software product that does something very specific, or a single device that does something very specific,” he said.

The cost and budgetary impact of technological advances is apparent across the entire industry, explained Macfarlane.

“There’s a linear relationship between increases in healthcare costs and the introduction of technology into the healthcare environment. When you introduce new technology, costs go up. We haven’t managed to bend that curve, at all,” he said.

Macfarlane also explained that the rapid adoption of healthcare IT systems can decrease the usage by the physicians it was designed to assist.

“They found that they sort of made their lives more complicated, not less complicated,” Macfarlane said. “They found that they spend more time now than they used to, entering data and a lot of hospitals have actually hired people to do that for physicians. So, there’s still a lot of maturity (for these systems) to achieve.”

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Recent Episodes

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…